Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
10.42 (1y: +36%)
Market Cap 381.34 M P/E(ttm) 47.40
Enterprise Value 578.11 M P/B 1.20
SMA- NYSE (USA)
Symmetry Medical, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$10.42
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry		 vs
history
Cash to Debt 0.046
SMA's Cash to Debt is ranked lower than
87% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. SMA: 0.046 )
SMA' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.05
Equity to Asset -0.051
SMA's Equity to Asset is ranked lower than
92% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. SMA: -0.051 )
SMA' s 10-Year Equity to Asset Range
Min: -0.38   Max: 0.33
Current: -0.05
-0.38
0.33
Interest Coverage 1.7
SMA's Interest Coverage is ranked lower than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 420.30 vs. SMA: 1.7 )
SMA' s 10-Year Interest Coverage Range
Min: 2   Max: 17
Current: 1.7
2
17
F-Score: 6
Z-Score: 1.7
M-Score: -2.97
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating margin (%) 8.00
SMA's Operating margin (%) is ranked higher than
71% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. SMA: 8.00 )
SMA' s 10-Year Operating margin (%) Range
Min: 2.3   Max: 19.3
Current: 8
2.3
19.3
Net-margin (%) 2.2
SMA's Net-margin (%) is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. SMA: 2.2 )
SMA' s 10-Year Net-margin (%) Range
Min: -9.7   Max: 12.1
Current: 2.2
-9.7
12.1
ROE (%) 2.9
SMA's ROE (%) is ranked higher than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. SMA: 2.9 )
SMA' s 10-Year ROE (%) Range
Min: -0.1   Max: 12.6
Current: 2.9
-0.1
12.6
ROA (%) 1.5
SMA's ROA (%) is ranked higher than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. SMA: 1.5 )
SMA' s 10-Year ROA (%) Range
Min: -9.6   Max: 9.4
Current: 1.5
-9.6
9.4
ROC (Joel Greenblatt) (%) 17.00
SMA's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. SMA: 17.00 )
SMA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.8   Max: 34.2
Current: 17
3.8
34.2
Revenue Growth (%) 2.3
SMA's Revenue Growth (%) is ranked higher than
60% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SMA: 2.3 )
SMA' s 10-Year Revenue Growth (%) Range
Min: -8.6   Max: 12
Current: 2.3
-8.6
12
EBITDA Growth (%) -0.8
SMA's EBITDA Growth (%) is ranked higher than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. SMA: -0.8 )
SMA' s 10-Year EBITDA Growth (%) Range
Min: -23.5   Max: 24.6
Current: -0.8
-23.5
24.6
EPS Growth (%) -20
SMA's EPS Growth (%) is ranked higher than
63% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. SMA: -20 )
SMA' s 10-Year EPS Growth (%) Range
Min: 0   Max: -3
Current: -20
ยป SMA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

SMA Guru Trades in Q2 2012

John Keeley 444,000 sh (New)
Chuck Royce 3,000 sh (unchged)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
John Rogers 5,342,955 sh (-6.26%)
» More
Q3 2012

SMA Guru Trades in Q3 2012

Jim Simons 23,000 sh (New)
John Keeley 1,751,694 sh (+294.53%)
Chuck Royce Sold Out
John Rogers 4,515,204 sh (-15.49%)
» More
Q4 2012

SMA Guru Trades in Q4 2012

Joel Greenblatt 61,357 sh (New)
Jim Simons 48,100 sh (+109.13%)
John Keeley 1,931,694 sh (+10.28%)
John Rogers 4,552,076 sh (+0.82%)
» More
Q1 2013

SMA Guru Trades in Q1 2013

Joel Greenblatt 163,685 sh (+166.77%)
Jim Simons 89,900 sh (+86.9%)
John Keeley 2,033,694 sh (+5.28%)
John Rogers 4,300,731 sh (-5.52%)
» More
» Details

Insider Trades

Latest Guru Trades with SMA

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Add 166.77%0.06%$10.13 - $11.45 $ 10.42-3%163685
Joel Greenblatt 2012-12-31 New Buy0.04%$8.27 - $10.61 $ 10.4211%61357
John Keeley 2012-09-30 Add 294.53%0.28%$7.51 - $10.02 $ 10.4218%1751694
John Keeley 2012-06-30 New Buy0.09%$6.7 - $8.71 $ 10.4237%444000
Joel Greenblatt 2011-09-30 Sold Out 0.0137%$7.27 - $10.01 $ 10.4222%0
George Soros 2011-09-30 Sold Out 0.0026%$7.27 - $10.01 $ 10.4222%0
Joel Greenblatt 2011-06-30 Reduce -26.17%0.01%$8.44 - $10.22 $ 10.429%10976
George Soros 2011-06-30 New Buy$8.44 - $10.22 $ 10.429%21000
Joel Greenblatt 2011-03-31 New Buy0.04%$8.63 - $9.94 $ 10.4211%14867
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 47.40
SMA's P/E(ttm) is ranked lower than
54% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. SMA: 47.40 )
SMA' s 10-Year P/E(ttm) Range
Min: 5.8   Max: 319.17
Current: 47.4
5.8
319.17
P/B 1.20
SMA's P/B is ranked higher than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. SMA: 1.20 )
SMA' s 10-Year P/B Range
Min: 0.6   Max: 3.78
Current: 1.2
0.6
3.78
P/S 0.90
SMA's P/S is ranked higher than
74% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. SMA: 0.90 )
SMA' s 10-Year P/S Range
Min: 0.37   Max: 3.1
Current: 0.9
0.37
3.1
PFCF 8.50
SMA's PFCF is ranked higher than
85% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 18.60 vs. SMA: 8.50 )
SMA' s 10-Year PFCF Range
Min: 6.67   Max: 198
Current: 8.5
6.67
198
EV-to-EBIT 19.2
SMA's EV-to-EBIT is ranked higher than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. SMA: 19.2 )
SMA' s 10-Year EV-to-EBIT Range
Min: 6.2   Max: 66.9
Current: 19.2
6.2
66.9
Shiller P/E 30
SMA's Shiller P/E is ranked higher than
85% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 23.60 vs. SMA: 30 )
SMA' s 10-Year Shiller P/E Range
Min: 13.59   Max: 34.31
Current: 30
13.59
34.31

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 5.2
SMA's Price/Net Current Asset Value is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. SMA: 5.2 )
SMA' s 10-Year Price/Net Current Asset Value Range
Min: 3.8   Max: 13.1
Current: 5.2
3.8
13.1
Price/DCF (Projected) 0.9
SMA's Price/DCF (Projected) is ranked higher than
76% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. SMA: 0.9 )
SMA' s 10-Year Price/DCF (Projected) Range
Min: 0.8   Max: 0.9
Current: 0.9
0.8
0.9
Price/Median PS Value 0.9
SMA's Price/Median PS Value is ranked higher than
65% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. SMA: 0.9 )
SMA' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 2.4
Current: 0.9
0.6
2.4
Earnings Yield (Greenblatt) 5.20
SMA's Earnings Yield (Greenblatt) is ranked lower than
81% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. SMA: 5.20 )
SMA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 16
Current: 5.2
1.5
16
Forward Rate of Return (Yacktman) -3.82
SMA's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. SMA: -3.82 )
SMA' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -12   Max: 6
Current: -3.82
-12
6

Business Description

Symmetry Medical, Inc. is a Delaware corporation incorporated on July 25, 1996. It is a global source of medical device products. Symmetry's OEM Solutions business is a global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. Its trusted reputation and brands, broad Intellectual Property portfolio and commitment to innovation enable it to collaborate with hundreds of global medical device manufacturers to provide solutions for today's needs and tomorrow's growth. It operates in two reportable segments: Original Equipment Manufacturer ("OEM") Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation ("SSI"). Symmetry Surgical, which is headquartered in Nashville,Tennessee. Symmetry Surgical offers a range of reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are typically used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's business is subject to governmental regulation. It is subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at the Company's facilities and at off-site disposal locations.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, ZMH, STJ, EW
ยป More Articles for SMA

Headlines

Articles On GuruFocus.com
John Rogers Ariel Fund Second-Quarter Portfolio Analysis Aug 08 2012 
Symmetry Medical Inc. Reports Operating Results (10-Q) Nov 10 2010 
Symmetry Medical Inc. Reports Operating Results (10-Q) Aug 06 2010 
Symmetry Medical Inc. Reports Operating Results (10-Q) May 11 2010 
Symmetry Medical Inc. Reports Operating Results (10-Q) Nov 10 2009 
Symmetry Medical Inc. Reports Operating Results (10-Q) Aug 07 2009 
Symmetry Medical Inc. Reports Operating Results (10-Q) May 08 2009 
Symmetry Medical Inc. (SMA) CFO Fred Hite buys 5,700 Shares Mar 06 2009 
Symmetry Medical Inc. (SMA) CEO Brian Moore buys 11,500 Shares Mar 06 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial